Morbidity, mortality and case fatality rate from liver cirrhosis in the age aspect in Kyrgyzstan for the period 2010–2017
https://doi.org/10.31146/1682-8658-ecg-176-4-83-88
Abstract
The purpose is to study the dynamics of morbidity, mortality and case fatality ratefrom liver cirrhosis in the age aspect from 2010–2017 in Kyrgyzstan.
Materials and methods: Analyzed state reporting forms No. 12 “Report on morbidity and preventive work (family medicine center, dispensary)” and “C51 — Distribution of deaths by sex, age groups and causes of death” from 2010–2017. Data processed by Microsoft Office Excel.
Results: The average cumulative prevalence of liver cirrhosis (K 74) in persons older than 15 years for the period 2010–2017 was 50.9 0/0000, the average incidence is 12.3 0/0000, the mortality is 45.2 0/0000. Persons over 75 years old had the highest mortality rate — 160, 7 0/0000, the age group “45–59 years old” occupied the third position (92.8 0/0000) after the persons “60–74 years old” (140.9 0/0000). It is necessary to emphasize the presence of mortality among children and individuals 15–24 years old, although the incidence rates (0.2 0/0000 and 2.5 0/0000, respectively) and the proportion (0.2 % and 1.6 %, respectively) were low. In the period 2015–2017 were registered 47 children with “K 74”, of which 15 were fi rst identifi ed, and for 2011–2017 yy. 32 children with a fatal outcome. Over the past 3 years there has been a tendency for the growth of all three indicators in children. For 2010–2017 yy. the average cumulative case fatality ratein persons over 15 years of age prevailed over children in 2,069.9 cases per 10,000 patients (8878.4 0/000 and 6808.5 0/000, respectively). The case fatality rateamong adults decreased 1.6 times (11176.8 0/000 and 6815.2 0/000, 2010 and 2017, respectively), and among children 1.5 times(4285.7 0/000 and 2857.1 0/000, 2015 and 2017, respectively).
Conclusion: On the basis of the obtained data, in order to improve the K 74 accounting system, an emergency notifi cation (Form No. 58u) was introduced in the country for newly detected and lethal cases of cirrhosis and liver cancer in the outcome of hepatitis B and C. To develop specifi c prevention measures and control strategies in general, the country needs a register of patients with cirrhosis and liver cancer with etiological interpretation.
Keywords
About the Authors
K. A. NogoibaevaKyrgyzstan
Department of Infectious Diseases, HIV / AIDS and dermatovenerology; Associate Professor; Department of General and Clinical Epidemiology, Associate Professor, PhD
Scopus ID:26640604900
Bishkek, Bokonbaeva 144a, 720040, Kyrgyzstan
Bishkek, Akhunbaeva 92, 700020, Kyrgyzstan
S. T. Tobokalova
Kyrgyzstan
Department of Infectious Diseases, HIV / AIDS and dermatovenerology, Head of the Department of Infectious Diseases, HIV / AIDS and Dermatovenereology, MD, Professor
Bishkek, Bokonbaeva 144a, 720040, Kyrgyzstan
S. I. Umarova
Kyrgyzstan
Department of Therapy No. 1, Faculty of Medicine, PhD, Associate Professor
Bishkek, Kiev 44, 720000, Kyrgyzstan
References
1. Silacheva MV, Grishchenko EG, Petrova MM, et al. Cirrhosis of the liver and stomach cancer: current state of the problem. Modern problems of science and education. 2015, no 3, 187 p.
2. Yakovenko A. V. Liver cirrhosis, clinical and pathogenetic aspects. Pharmateca. 2012, vol. 13, no 246, pp. 32–36.
3. Mayer KP Hepatitis and the consequences of hepatitis: practical. hands.: Per. with him / ed. A. A. Sheptulina. Moscow. Geotar medicine, 2000, 432 p.
4. Lin J., Wu J.-F., Zhang Q. Virus-related liver cirrhosis: molecular basis and therapeutic option. World J. Gastroenterol, 2014, vol. 7, no 20, pp. 6457–6469
5. Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the global burden disease study. 2013. Lancet 2016, vol. 388 pp.1081–1088.
6. Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C infection. Geneva: World Health Organization; 2019. License: CC BY-NC-SA 3.0 IGO.
7. Bogomolov P. O., Macievich M. V., Buyever A. O., Kokina K. Yu., Voronkova N. V., Beznosenko V. D. Liver cirrhosis in the Moscow region: figures and facts. Almanac of clinical medicine. 2018, vol. 46, no 1, pp. 59–67. doi: 10.18786 / 2072–0505–2018–46–1–59–67
8. Tobokalova S. T., Bekenova DS, Zairova G. M. et al. Epidemiological features of acute and chronic hepatitis B in the Kyrgyz Republic over a 20-year period (1997–2017). Kazan Medical Journal. 2018, vol. 99, no 6, pp. 986–993.
9. “Report on morbidity and preventive work (family medicine center, dispensary)”, State Reporting Form No. 12. –E-Health Center of the Ministry of Health of the Kyrgyz Republic. Reporting form “C51 – Distribution of deceased by sex, age groups and causes of death” http://cez.med.kg/
10. The resident population by sex and age groups” National Statistical Committee of the Kyrgyz Republic.. http://www.stat.kg/ru/
11. “WHO Age Classification” https://citifox.ru/2016/05/05/ vozrastnaya-klassifi kaciya-vsemirnoy
12. Exact Binomial and Poisson Confidence Intervals. http://statpages.info/confint.html
13. Stanton A. Glantz. Primer of biostatistics (trans. from English). Moscow, 1998, 213 p.
14. “Guidelines on epidemiological surveillance of viral hepatitis in the Kyrgyz Republic”, approved by order of the Ministry of Health of the Kyrgyz Republic no. 524 dated 07. 20. 2018. http://www.npopm.kg/ru/
Review
For citations:
Nogoibaeva K.A., Tobokalova S.T., Umarova S.I. Morbidity, mortality and case fatality rate from liver cirrhosis in the age aspect in Kyrgyzstan for the period 2010–2017. Experimental and Clinical Gastroenterology. 2020;174(4):83-88. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-176-4-83-88